Plexus Announces Fiscal Second Quarter Financial Results
Plexus Corp. (NASDAQ: PLXS) reported fiscal second quarter 2023 revenues of $1.07 billion, reflecting a 21% year-over-year growth. The GAAP operating margin stood at 5.3% with a GAAP diluted EPS of $1.45. For the upcoming fiscal third quarter, the company projects revenue between $1.00 billion and $1.05 billion and a GAAP EPS ranging from $0.76 to $0.94, factoring in approximately $0.29 for restructuring charges. Plexus won 31 new manufacturing programs worth $275 million in annualized revenue during the second quarter, strengthening its sales pipeline to $4.2 billion. The company generated $80 million in free cash flow, nearly double its net income. However, the guidance reflects potential supply chain challenges and semiconductor market weakness.
- Fiscal Q2 2023 revenue grew 21% year-over-year to $1.07 billion.
- GAAP diluted EPS for Q2 reached $1.45.
- Secured 31 new manufacturing programs valued at $275 million in annualized revenue.
- Free cash flow of $80 million, nearly double the net income.
- Strong sales pipeline expanded to $4.2 billion.
- Q3 revenue guidance of $1.00 billion to $1.05 billion reflects potential supply chain challenges.
- GAAP EPS guidance for Q3 is lower at $0.76 to $0.94.
NEENAH, WI, April 26, 2023 (GLOBE NEWSWIRE) -- Plexus Corp. (NASDAQ: PLXS) today announced financial results for our fiscal second quarter ended April 1, 2023, and guidance for our fiscal third quarter ending July 1, 2023.
- Reports fiscal second quarter 2023 revenue of
$1.07 billion , GAAP operating margin of5.3% and GAAP diluted EPS of$1.45 , including$0.21 of stock-based compensation expense - Initiates fiscal third quarter 2023 revenue guidance of
$1.00 billion to$1.05 billion with GAAP diluted EPS of$0.76 t o$0.94 , including$0.19 of stock-based compensation expense and approximately$0.29 of restructuring and other charges
Three Months Ended | |||||
Apr 1, 2023 | Apr 1, 2023 | Jul 1, 2023 | |||
Q2F23 Results | Q2F23 Guidance | Q3F23 Guidance | |||
Summary GAAP Items | |||||
Revenue (in billions) | |||||
Operating margin (1) | |||||
Diluted EPS (2) | |||||
Summary Non-GAAP Items (3) | |||||
Adjusted operating margin (4) | |||||
Adjusted diluted EPS (5) | |||||
Return on invested capital (ROIC) | |||||
Economic return | |||||
(1) Includes restructuring and other charges of approximately 90 bps in operating margin for Q3F23 guidance. (2) Includes stock-based compensation expense of (3) Refer to Non-GAAP Supplemental Information in Tables 1 and 2 for additional information regarding non-GAAP financial measures. (4) Excludes restructuring and other charges of approximately 90 bps. (5) Excludes restructuring and other charges of approximately | |||||
Fiscal Second Quarter 2023 Information
- Won 31 manufacturing programs during the quarter representing
$275 million in annualized revenue when fully ramped into production - Trailing four-quarter manufacturing wins of
$847 million in annualized revenue when fully ramped into production - Purchased
$12.4 million of our shares at an average price of$98.75 per share under our share repurchase program, leaving$22.6 million available under our current$50.0 million authorization
Todd Kelsey, Chief Executive Officer commented, “Our team continues to execute well amidst ongoing market volatility and supply chain challenges. Plexus delivered fiscal second quarter revenue of
Mr. Kelsey continued, “I’m extremely pleased with the strong performance of our go-to-market organization. Our team won 31 new manufacturing programs worth
Patrick Jermain, Executive Vice President and Chief Financial Officer, commented, “We generated
Mr. Kelsey further commented, “We are guiding fiscal third quarter revenue of
Mr. Kelsey concluded, “As we near completion of our annual strategic planning process, I remain convinced in our ability to drive robust revenue growth and strong profitability, including achieving our target of
Quarterly Comparison | Three Months Ended | ||||||||||
(in thousands, except EPS) | Apr 1, 2023 | Dec 31, 2022 | Apr 2, 2022 | ||||||||
Revenue | $ | 1,070,823 | $ | 1,093,925 | $ | 888,723 | |||||
Gross profit | 102,993 | 101,199 | 76,510 | ||||||||
Operating income | 56,942 | 57,341 | 35,837 | ||||||||
Net income | 40,844 | 42,190 | 26,869 | ||||||||
Diluted EPS | $ | 1.45 | $ | 1.49 | $ | 0.95 | |||||
Gross margin | 9.6 | % | 9.3 | % | 8.6 | % | |||||
Operating margin | 5.3 | % | 5.2 | % | 4.0 | % | |||||
ROIC (1) | 13.8 | % | 13.8 | % | 10.2 | % | |||||
Economic return (1) | 4.8 | % | 4.8 | % | 0.9 | % | |||||
(1) Refer to Non-GAAP Supplemental Information in Tables 1 and 2 for non-GAAP financial measures discussed and/or disclosed in this release, such as adjusted operating margin, adjusted net income, adjusted diluted EPS, ROIC and economic return. | |||||||||||
Business Segment and Market Sector Revenue
Plexus measures operational performance and allocates resources on a geographic segment basis. Plexus also reports revenue based on the market sector breakout set forth in the table below, which reflects Plexus’ market sector focused strategy. Top 10 customers comprised
Business Segments ($ in millions) | Three Months Ended | ||||||||||
Apr 1, 2023 | Dec 31, 2022 | Apr 2, 2022 | |||||||||
Americas | $ | 408 | $ | 390 | $ | 311 | |||||
Asia-Pacific | 587 | 642 | 534 | ||||||||
Europe, Middle East and Africa | 102 | 89 | 74 | ||||||||
Elimination of inter-segment sales | (26 | ) | (27 | ) | (30 | ) | |||||
Total Revenue | $ | 1,071 | $ | 1,094 | $ | 889 |
Market Sectors ($ in millions) | Three Months Ended | ||||||||||||||||
Apr 1, 2023 | Dec 31, 2022 | Apr 2, 2022 | |||||||||||||||
Industrial | $ | 439 | 41 | % | $ | 472 | 43 | % | $ | 415 | 47 | % | |||||
Healthcare/Life Sciences | 488 | 46 | % | 488 | 45 | % | 353 | 40 | % | ||||||||
Aerospace/Defense | 144 | 13 | % | 134 | 12 | % | 121 | 13 | % | ||||||||
Total Revenue | $ | 1,071 | $ | 1,094 | $ | 889 | |||||||||||
Non-GAAP Supplemental Information
Plexus provides non-GAAP supplemental information, such as ROIC, economic return and free cash flow because such measures are used for internal management goals and decision-making, and because they provide management and investors with additional insight into financial performance. In addition, management uses these and other non-GAAP measures, such as adjusted operating income, adjusted operating margin, adjusted net income and adjusted diluted EPS, to provide a better understanding of core performance for purposes of period-to-period comparisons. Plexus believes that these measures are also useful to investors because they provide further insight by eliminating the effect of non-recurring items that are not reflective of continuing operations. For additional information on non-GAAP measures, please refer to the attached Non-GAAP Supplemental Information tables.
ROIC and Economic Return
ROIC for the second quarter of fiscal 2023 was
Free Cash Flow
Plexus defines free cash flow as cash flows provided by operations less capital expenditures. For the three months ended April 1, 2023, cash flows provided by operations of
Cash Cycle Days | Three Months Ended | |||||||
Apr 1, 2023 | Dec 31, 2022 | Apr 2, 2022 | ||||||
Days in Accounts Receivable | 56 | 61 | 59 | |||||
Days in Contract Assets | 11 | 10 | 12 | |||||
Days in Inventory | 156 | 151 | 154 | |||||
Days in Accounts Payable | (69 | ) | (69 | ) | (86 | ) | ||
Days in Cash Deposits | (50 | ) | (47 | ) | (41 | ) | ||
Annualized Cash Cycle * | 104 | 106 | 98 | |||||
* We calculate cash cycle as the sum of days in accounts receivable, days in contract assets and days in inventory, less days in accounts payable and days in cash deposits. | ||||||||
Conference Call and Webcast Information
What: | Plexus Fiscal 2023 Q2 Earnings Conference Call and Webcast |
When: | Thursday, April 27, 2023 at 8:30 a.m. Eastern Time |
Where: | Participants are encouraged to join the live webcast at the investor relations section of the Plexus website, plexus.com. Participants can also join utilizing the links below: Audio conferencing link: https://register.vevent.com/register/BIcf715026af574a01b337bf55806f00a6 Webcast link: https://edge.media-server.com/mmc/p/ug4v23ev |
Replay: | The webcast will be archived on the Plexus website and will be available as on-demand for 12 months |
Investor and Media Contact
Shawn Harrison
+1.920.969.6325
shawn.harrison@plexus.com
About Plexus
Since 1979, Plexus has been partnering with companies to create the products that build a better world. We are a team of nearly 25,000 individuals who are dedicated to providing Design and Development, Supply Chain Solutions, New Product Introduction, Manufacturing and Sustaining Services. Plexus is a global leader that specializes in serving customers in industries with highly complex products and demanding regulatory environments. Plexus delivers customer service excellence to leading companies by providing innovative, comprehensive solutions throughout a product’s lifecycle. For more information about Plexus, visit our website at www.plexus.com.
Safe Harbor and Fair Disclosure Statement
The statements contained in this press release that are guidance or which are not historical facts (such as statements in the future tense and statements including believe, expect, intend, plan, anticipate, goal, target and similar terms and concepts), including all discussions of periods which are not yet completed, are forward-looking statements that involve risks and uncertainties. These risks and uncertainties include the effect of inflationary pressures on our costs of production, profitability, and on the economic outlook of our markets; the effects of shortages and delays in obtaining components as a result of economic cycles, natural disasters or otherwise; the risk of customer delays, changes, cancellations or forecast inaccuracies in both ongoing and new programs; the ability to realize anticipated savings from restructuring or similar actions, as well as the adequacy of related charges as compared to actual expenses; the lack of visibility of future orders, particularly in view of changing economic conditions; the economic performance of the industries, sectors and customers we serve; the outcome of litigation and regulatory investigations and proceedings; the effects of tariffs, trade disputes, trade agreements and other trade protection measures; the effects of the volume of revenue from certain sectors or programs on our margins in particular periods; our ability to secure new customers, maintain our current customer base and deliver product on a timely basis; the risks of concentration of work for certain customers; the particular risks relative to new or recent customers, programs or services, which risks include customer and other delays, start-up costs, potential inability to execute, the establishment of appropriate terms of agreements, and the lack of a track record of order volume and timing; the effects of start-up costs of new programs and facilities or the costs associated with the closure or consolidation of facilities; possible unexpected costs and operating disruption in transitioning programs, including transitions between Company facilities; the risk that new program wins and/or customer demand may not result in the expected revenue or profitability; the fact that customer orders may not lead to long-term relationships; our ability to manage successfully and execute a complex business model characterized by high product mix and demanding quality, regulatory, and other requirements; the risks associated with excess and obsolete inventory, including the risk that inventory purchased on behalf of our customers may not be consumed or otherwise paid for by the customer, resulting in an inventory write-off; risks related to information technology systems and data security; increasing regulatory and compliance requirements; any tax law changes and related foreign jurisdiction tax developments; current or potential future barriers to the repatriation of funds that are currently held outside of the United States as a result of actions taken by other countries or otherwise; the potential effects of jurisdictional results on our taxes, tax rates, and our ability to use deferred tax assets and net operating losses; the weakness of areas of the global economy; the effect of changes in the pricing and margins of products; raw materials and component cost fluctuations; the potential effect of fluctuations in the value of the currencies in which we transact business; the effects of changes in economic conditions, political conditions and tax matters in the United States and in the other countries in which we do business; the potential effect of other world or local events or other events outside our control (such as the conflict between Russia and Ukraine, escalating tensions between China and Taiwan or China and the United States, changes in energy prices, terrorism, global health epidemics and weather events); the impact of increased competition; an inability to successfully manage human capital; changes in financial accounting standards; and other risks detailed herein and in our other Securities and Exchange Commission filings, particularly in Risk Factors contained in our fiscal 2022 Form 10-K.
PLEXUS CORP. AND SUBSIDIARIES | ||||||||||||||||
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS | ||||||||||||||||
(in thousands, except per share data) | ||||||||||||||||
(unaudited) | ||||||||||||||||
Three Months Ended | Six Months Ended | |||||||||||||||
Apr 1, | Apr 2, | Apr 1, | Apr 2, | |||||||||||||
2023 | 2022 | 2023 | 2022 | |||||||||||||
Net sales | $ | 1,070,823 | $ | 888,723 | $ | 2,164,748 | $ | 1,706,179 | ||||||||
Cost of sales | 967,830 | 812,213 | 1,960,556 | 1,559,673 | ||||||||||||
Gross profit | 102,993 | 76,510 | 204,192 | 146,506 | ||||||||||||
Operating expenses: | ||||||||||||||||
Selling and administrative expenses | 46,051 | 40,673 | 89,909 | 78,175 | ||||||||||||
Restructuring and impairment charges | — | — | — | 2,021 | ||||||||||||
Operating income | 56,942 | 35,837 | 114,283 | 66,310 | ||||||||||||
Other income (expense): | ||||||||||||||||
Interest expense | (8,287 | ) | (3,345 | ) | (15,181 | ) | (6,391 | ) | ||||||||
Interest income | 759 | 262 | 1,693 | 533 | ||||||||||||
Miscellaneous, net | (1,612 | ) | (1,446 | ) | (3,556 | ) | (2,369 | ) | ||||||||
Income before income taxes | 47,802 | 31,308 | 97,239 | 58,083 | ||||||||||||
Income tax expense | 6,958 | 4,439 | 14,205 | 7,791 | ||||||||||||
Net income | $ | 40,844 | $ | 26,869 | $ | 83,034 | $ | 50,292 | ||||||||
Earnings per share: | ||||||||||||||||
Basic | $ | 1.48 | $ | 0.96 | $ | 3.00 | $ | 1.80 | ||||||||
Diluted | $ | 1.45 | $ | 0.95 | $ | 2.94 | $ | 1.76 | ||||||||
Weighted average shares outstanding: | ||||||||||||||||
Basic | 27,661 | 27,987 | 27,650 | 28,002 | ||||||||||||
Diluted | 28,184 | 28,427 | 28,273 | 28,566 |
PLEXUS CORP. AND SUBSIDIARIES | ||||||||
CONDENSED CONSOLIDATED BALANCE SHEETS | ||||||||
(in thousands, except per share data) | ||||||||
(unaudited) | ||||||||
Apr 1, | Oct 1, | |||||||
2023 | 2022 | |||||||
ASSETS | ||||||||
Current assets: | ||||||||
Cash and cash equivalents | $ | 269,664 | $ | 274,805 | ||||
Restricted cash | 700 | 665 | ||||||
Accounts receivable | 661,445 | 737,696 | ||||||
Contract assets | 133,029 | 138,540 | ||||||
Inventories | 1,649,719 | 1,602,783 | ||||||
Prepaid expenses and other | 65,717 | 61,633 | ||||||
Total current assets | 2,780,274 | 2,816,122 | ||||||
Property, plant and equipment, net | 469,387 | 444,705 | ||||||
Operating lease right-of-use assets | 62,795 | 65,134 | ||||||
Deferred income taxes | 39,405 | 39,075 | ||||||
Other assets | 30,159 | 28,189 | ||||||
Total non-current assets | 601,746 | 577,103 | ||||||
Total assets | $ | 3,382,020 | $ | 3,393,225 | ||||
LIABILITIES AND SHAREHOLDERS’ EQUITY | ||||||||
Current liabilities: | ||||||||
Current portion of long-term debt and finance lease obligations | $ | 294,011 | $ | 273,971 | ||||
Accounts payable | 729,225 | 805,583 | ||||||
Customer deposits | 531,683 | 480,486 | ||||||
Accrued salaries and wages | 76,702 | 88,876 | ||||||
Other accrued liabilities | 286,241 | 357,273 | ||||||
Total current liabilities | 1,917,862 | 2,006,189 | ||||||
Long-term debt and finance lease obligations, net of current portion | 188,730 | 187,776 | ||||||
Accrued income taxes payable | 31,382 | 42,019 | ||||||
Long-term operating lease liabilities | 31,257 | 33,628 | ||||||
Deferred income taxes | 4,901 | 6,327 | ||||||
Other liabilities | 25,506 | 21,555 | ||||||
Total non-current liabilities | 281,776 | 291,305 | ||||||
Total liabilities | 2,199,638 | 2,297,494 | ||||||
Shareholders’ equity: | ||||||||
Common stock, $.01 par value, 200,000 shares authorized, | ||||||||
54,293 and 54,084 shares issued, respectively, | ||||||||
and 27,647 and 27,679 shares outstanding, respectively | 543 | 541 | ||||||
Additional paid-in-capital | 651,667 | 652,467 | ||||||
Common stock held in treasury, at cost, 26,646 and 26,405, respectively | (1,117,360 | ) | (1,093,483 | ) | ||||
Retained earnings | 1,655,268 | 1,572,234 | ||||||
Accumulated other comprehensive loss | (7,736 | ) | (36,028 | ) | ||||
Total shareholders’ equity | 1,182,382 | 1,095,731 | ||||||
Total liabilities and shareholders’ equity | $ | 3,382,020 | $ | 3,393,225 |
PLEXUS CORP. AND SUBSIDIARIES | ||||||||||||||||||||
NON-GAAP SUPPLEMENTAL INFORMATION Table 1 | ||||||||||||||||||||
(in thousands, except per share data) | ||||||||||||||||||||
(unaudited) | ||||||||||||||||||||
Three Months Ended | Six Months Ended | |||||||||||||||||||
Apr 1, | Dec 31, | Apr 2, | Apr 1, | Apr 2, | ||||||||||||||||
2023 | 2022 | 2022 | 2023 | 2022 | ||||||||||||||||
Operating income, as reported | $ | 56,942 | $ | 57,341 | $ | 35,837 | $ | 114,283 | $ | 66,310 | ||||||||||
Operating margin, as reported | 5.3 | % | 5.2 | % | 4.0 | % | 5.3 | % | 3.9 | % | ||||||||||
Non-GAAP adjustments: | ||||||||||||||||||||
Restructuring and impairment charges (1) | — | — | — | — | 2,021 | |||||||||||||||
Adjusted operating income | $ | 56,942 | $ | 57,341 | $ | 35,837 | $ | 114,283 | $ | 68,331 | ||||||||||
Adjusted operating margin | 5.3 | % | 5.2 | % | 4.0 | % | 5.3 | % | 4.0 | % | ||||||||||
Net income, as reported | $ | 40,844 | $ | 42,190 | $ | 26,869 | $ | 83,034 | $ | 50,292 | ||||||||||
Non-GAAP adjustments: | ||||||||||||||||||||
Restructuring and impairment charges, net of tax (1) | — | — | — | — | 1,809 | |||||||||||||||
Adjusted net income | $ | 40,844 | $ | 42,190 | $ | 26,869 | $ | 83,034 | $ | 52,101 | ||||||||||
Diluted earnings per share, as reported | $ | 1.45 | $ | 1.49 | $ | 0.95 | $ | 2.94 | $ | 1.76 | ||||||||||
Non-GAAP per share adjustments: | ||||||||||||||||||||
Restructuring and impairment charges, net of tax (1) | — | — | — | — | 0.06 | |||||||||||||||
Adjusted diluted earnings per share | $ | 1.45 | $ | 1.49 | $ | 0.95 | $ | 2.94 | $ | 1.82 | ||||||||||
(1) During the six months ended April 2, 2022, restructuring and impairment charges of |
PLEXUS CORP. AND SUBSIDIARIES | ||||||||||||||
NON-GAAP SUPPLEMENTAL INFORMATION Table 2 | ||||||||||||||
(in thousands) | ||||||||||||||
(unaudited) | ||||||||||||||
ROIC and Economic Return Calculations | Six Months Ended | Three Months Ended | Six Months Ended | |||||||||||
Apr 1, | Dec 31, | Apr 2, | ||||||||||||
2023 | 2022 | 2022 | ||||||||||||
Operating income, as reported | $ | 114,283 | $ | 57,341 | $ | 66,310 | ||||||||
Restructuring and impairment charges | + | — | + | — | + | 2,021 | ||||||||
Adjusted operating income | $ | 114,283 | $ | 57,341 | $ | 68,331 | ||||||||
x | 2 | x | 4 | x | 2 | |||||||||
Adjusted annualized operating income | $ | 228,566 | $ | 229,364 | $ | 136,662 | ||||||||
Adjusted effective tax rate | x | 15 | % | x | 16 | % | x | 14 | % | |||||
Tax impact | 34,285 | 36,698 | 19,133 | |||||||||||
Adjusted operating income (tax-effected) | $ | 194,281 | $ | 192,666 | $ | 117,529 | ||||||||
Average invested capital | ÷ | $ | 1,406,359 | ÷ | $ | 1,392,002 | ÷ | $ | 1,151,775 | |||||
ROIC | 13.8 | % | 13.8 | % | 10.2 | % | ||||||||
Weighted average cost of capital | - | 9.0 | % | - | 9.0 | % | - | 9.3 | % | |||||
Economic return | 4.8 | % | 4.8 | % | 0.9 | % |
Average Invested Capital Calculations | Apr 1, | Dec 31, | Oct 1, | Jul 2, | Apr 2, | Jan 1, | Oct 2, | |||||||||||||||||||||
2023 | 2022 | 2022 | 2022 | 2022 | 2022 | 2021 | ||||||||||||||||||||||
Equity | $ | 1,182,382 | $ | 1,150,259 | $ | 1,095,731 | $ | 1,058,190 | $ | 1,040,591 | $ | 1,044,095 | $ | 1,028,232 | ||||||||||||||
Plus: | ||||||||||||||||||||||||||||
Debt and finance lease obligations - current | 294,011 | 329,076 | 273,971 | 250,012 | 222,393 | 151,417 | 66,313 | |||||||||||||||||||||
Operating lease obligations - current (1) | 8,358 | 8,878 | 7,948 | 8,640 | 9,266 | 9,507 | 9,877 | |||||||||||||||||||||
Debt and finance lease obligations - long-term | 188,730 | 187,272 | 187,776 | 184,707 | 186,069 | 187,075 | 187,033 | |||||||||||||||||||||
Operating lease obligations - long-term | 31,257 | 32,149 | 33,628 | 32,270 | 34,347 | 36,343 | 37,970 | |||||||||||||||||||||
Less: | ||||||||||||||||||||||||||||
Cash and cash equivalents | (269,664 | ) | (247,880 | ) | (274,805 | ) | (276,608 | ) | (307,964 | ) | (217,067 | ) | (270,172 | ) | ||||||||||||||
$ | 1,435,074 | $ | 1,459,754 | $ | 1,324,249 | $ | 1,257,211 | $ | 1,184,702 | $ | 1,211,370 | $ | 1,059,253 | |||||||||||||||
(1) Included in other accrued liabilities on the Condensed Consolidated Balance Sheets. |
FAQ
What were Plexus Corp.'s second quarter earnings results for fiscal 2023?
What is Plexus Corp.'s guidance for the third quarter of fiscal 2023?
How much free cash flow did Plexus generate in Q2 2023?
What significant contracts did Plexus win in Q2 2023?